Pfizer Inc (PFIZ34)
BOV
Quarter End | 12 2022 | 4 2023 | 7 2023 | 10 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 24.29B | 18.28B | 12.73B | 13.23B | 14.25B | 14.88B | 13.28B | 17.7B |
営業利益 | 4.32B | 6.41B | 2.08B | -3.3B | -7.48B | 4.01B | 1.04B | 5.11B |
税引前収入 | 5.23B | 6.27B | 2.27B | -3.35B | -4.13B | 3.42B | -103M | 4.72B |
純利益 | 4.99B | 5.54B | 2.33B | -2.38B | -3.37B | 3.12B | 41M | 4.47B |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 5.33B | 7.13B | 2.33B | -2.79B | -6.61B | 4.17B | 786M | 5.28B |
EBITDA | 6.06B | 7.9B | 3.65B | -1.74B | -2.79B | 5.75B | 2.78B | 6.86B |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 52.82B | 52.55B | 53.65B | 59.84B | 41.91B | 81.29B | 100.33B | 58.5B |
営業利益 | 11.14B | 13.28B | 10.9B | 18.48B | 6.77B | 19.82B | 34.96B | -2.3B |
税引前収入 | 8.35B | 12.31B | 11.89B | 17.68B | 7.5B | 24.31B | 34.73B | 1.06B |
純利益 | 7.21B | 21.31B | 11.15B | 16.27B | 9.62B | 21.98B | 31.37B | 2.12B |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 1.188 | 3.563 | 1.951 | 2.94 | 1.727 | 3.91 | 5.585 | 0.375 |
EBIT | 11.36B | 13.3B | 13.02B | 19.07B | 8.87B | 24.22B | 36.99B | 53M |
EBITDA | 17.76B | 19.89B | 20.39B | 27.29B | 13.24B | 25.1B | 40.44B | 7.02B |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約